IGF2BP3 and central nervous system cancer: For instance, the high expression of circNEIL3 in glioma cells was found to block the binding between IGF2BP3 and HECTD4, via the modulation of protein ubiquitination and degradation, as well as cellular immunosuppressive responses, thereby promoting malignant progression of glioma [76].